Pricing Log in Create free account

InterCure Ltd. (INCR) vs Incannex Healthcare Inc. (IXHL)

InterCure Ltd. and Incannex Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. InterCure Ltd. is the larger, with a market value of $55.1M against $36.1M — 1.5× the size. Incannex Healthcare Inc. has negative trailing earnings, so its P/E is not meaningful; InterCure Ltd. trades at 8.8×. InterCure Ltd. has the higher net margin (4.88% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, InterCure Ltd. leads on 10 and Incannex Healthcare Inc. on 5.

Valuation

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
P/E 8.80 n/m 19.25
P/S 0.33 21.06 2.11
P/B 0.33 0.49 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA 7.24 1.36 12.58
EV/Sales 0.66 (19.90) 2.73
Earnings yield 11.36% (60.71%) (4.38%)
Free cash flow yield (2.02%) (39.17%) 0.00%

Profitability

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
Gross margin 32.74% (0.10%) 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 4.88% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (47.80%) (0.40%)
Return on assets 0.00% (41.32%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 16.15% — 10.01%
EPS growth (last fiscal year) 52.50% 95.91% 49.06%
Revenue growth, 5-year CAGR 31.11% (29.64%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
Debt to equity 0.27 0.00 0.05
Current ratio 1.85 48.81 2.31
Net debt to EBITDA (4.07) 2.97 0.97

Dividend

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
Market cap 55.10m 36.12m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack